Novel CaMKII-δ Inhibitor Hesperadin Exerts Dual Functions to Ameliorate Cardiac Ischemia/Reperfusion Injury and Inhibit Tumor Growth.
Circulation. 2022 Apr 12;145(15):1154-1168. doi: 10.1161/CIRCULATIONAHA.121.055920. Epub 2022 Mar 23.
Circulation. 2022.
PMID: 35317609
Free article.